Cutting Edge Urology

T his PDF belongs to matthew.hooson@springer.co 44 • CUTTING EDGE - UROLOGY 4. Washington SL, BonhamM, Whitson JM et al (2012) Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer. BJU Int 110(1):50–55. 5. Belas O, Hupertan V, Comperat E et al (2012) Low accuracy of routine ultrasound-guided systematic 12-core biopsies in prostate tumor mapping. Can J Urol 19(4):6366–6372. 6. Loeb S, Carter HB, Berndt SI et al (2011) Complications after prostate biopsy: data from SEERMedicare. J Urol 186(5):1830–1834. 7. Fütterer JJ, Briganti A, De Visschere P et al (2015) Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol 68(4):738. [Epub ahead of print]. 8. Rud E, Klotz D, Rennesund K et al (2014) Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone. BJU Int 114(6b):E32–42. 9. Tan CH, Paul Hobbs B, Wei W et al (2015) Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol 204(4):W439–W448. 10. Turkbey B, Merino MJ, Gallardo EC et al (2014) Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology. J Magn Reson Imaging 39(6):1443–1448. 11. Jung JA, Coakley FV, Vigneron DB et al (2004) Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology 233(3):701–708. 12. Barentsz JO, Richenberg J, Clements R et al (2012) ESUR prostate MR guidelines 2012. Eur Radiol 22(4):746–757. 13. Vargas HA, Hötker AM, Goldman DA et al (2015) Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference. Eur Radiol 26(6):1606–12. [Epub ahead of print]. 14. Pokorny MR, de Rooij M, Duncan E et al (2014) Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasoundguided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol 66(1):22–29. 15. Quentin M, Blondin D, Arsov C et al (2014) Prospective evaluation of magnetic resonance imaging guided in- bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen. J Urol 192(5):1374–1379. 16. Kasivisvanathan V, Dufour R, Moore CM et al (2013) Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer. J Urol 189(3):860–866. 17. Haffner J, Lemaitre L, Puech P et al (2011) Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy f r significant prostate cancer detection. BJU Int 108(8 Pt 2):E171–178. 18. Byrne TE (2005) A review of prostate motion with considerations for the treatment of prostate cancer. Med Dosim 30(3):155–161. 19. Logan JK, Rais-Bahrami S, Turkbey B et al (2014) Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies. BJU Int 114(5):641–652. 20. SonnGA, ChangE, NatarajanS etal (2014) Valueof targetedprostatebiopsy usingmagnetic resonanceultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol 65(4):809–815. 21. Lawrence EM, Tang SY, Barrett T et al (2014) Prostate cancer: performance characteristics of combined T2W and DW-MRI scoring in the setting of template transperineal re-biopsy using MR-TRUS fusion. Eur Radiol 24(7): 1497–1505. 22. Vourgant i S, Rastinehad A, Yerram N K et al (2012) Multiparametric magnetic resonance imaging and ultrasound fusion bio psy detect prostate c ancer in patients with prior negative transrectal ultrasound biopsies. J Urol 188(6):2152– 2157. 23. Abdi H, Zargar H , Goldenb erg SL et al (2015) Multiparametric magnetic resonance imagingtargeted biopsy for the detection of pr ostat e cancer in patients with prior negative biopsy results. Urol Oncol 33(4):165.e1–7. 24. Portalez D, Mozer P, Cornud F et al (2012) Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. Eur Urol 62(6):986–996. 25. Salami SS, Ben-Levi E, Yaskiv O et al (2015) In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy? BJU Int 115(4):562–570. Cutting EDGE_Urology(SUN)_final.indd 44 27-Mar-18 10:00:32 AM